Earnings Reports | Smart Investors Daily

earnings beatFATEfinnhubNov 5, 2026

Fate Therapeutics (FATE) Beats Q3 Earnings Estimates by $0.01

Fate Therapeutics (NASDAQ:FATE) reported quarterly earnings results on November 05, 2026 that exceeded analyst expectations.

earnings beatFLNAfinnhubNov 5, 2026

Filana Therapeutics (FLNA) Beats Q3 Earnings Estimates by $0.02

Filana Therapeutics (NASDAQ:FLNA) reported quarterly earnings results on November 05, 2026 that exceeded analyst expectations.

earnings beatKRROfinnhubNov 5, 2026

Korro Bio (KRRO) Beats Q3 Earnings Estimates by $0.26

Korro Bio (NASDAQ:KRRO) reported quarterly earnings results on November 05, 2026 that exceeded analyst expectations.

earnings beatCABAfinnhubNov 5, 2026

Cabaletta Bio (CABA) Beats Q3 Earnings Estimates by $0.03

Cabaletta Bio (NASDAQ:CABA) reported quarterly earnings results on November 05, 2026 that exceeded analyst expectations.

earnings missSCYXfinnhubNov 5, 2026

SCYNEXIS (SCYX) Misses Q3 Earnings Expectations

SCYNEXIS (NASDAQ:SCYX) reported quarterly earnings results on November 05, 2026 that fell short of analyst expectations.

earnings missDYNfinnhubNov 5, 2026

Dyne Therapeutics (DYN) Misses Q3 Earnings Expectations

Dyne Therapeutics (NASDAQ:DYN) reported quarterly earnings results on November 05, 2026 that fell short of analyst expectations.

earnings beatPYXSfinnhubNov 5, 2026

Pyxis Oncology (PYXS) Beats Q3 Earnings Estimates by $0.04

Pyxis Oncology (NASDAQ:PYXS) reported quarterly earnings results on November 05, 2026 that exceeded analyst expectations.

earnings beatRXSTfinnhubNov 4, 2026

RxSight (RXST) Beats Q3 Earnings Estimates by $0.02

RxSight (NASDAQ:RXST) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings beatMTWfinnhubNov 4, 2026

Manitowoc Co (MTW) Beats Q3 Earnings Estimates by $0.11

Manitowoc Co (NYSE:MTW) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings missIPIfinnhubNov 4, 2026

Intrepid Potash (IPI) Misses Q3 Earnings Expectations

Intrepid Potash (NYSE:IPI) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.

earnings missGSMfinnhubNov 4, 2026

Ferroglobe (GSM) Misses Q3 Earnings Expectations

Ferroglobe (NASDAQ:GSM) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.

earnings beatPRIMfinnhubNov 4, 2026

Primoris Services (PRIM) Beats Q3 Earnings Estimates by $0.43

Primoris Services (NYSE:PRIM) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings beatJELDfinnhubNov 4, 2026

JELD-WEN Holding (JELD) Beats Q3 Earnings Estimates by $0.01

JELD-WEN Holding (NYSE:JELD) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings beatTREEfinnhubNov 4, 2026

LendingTree (TREE) Beats Q3 Earnings Estimates by $0.70

LendingTree (NASDAQ:TREE) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings missSAFEfinnhubNov 4, 2026

Safehold (SAFE) Misses Q3 Earnings Expectations

Safehold (NYSE:SAFE) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.

earnings beatZVRAfinnhubNov 4, 2026

Zevra Therapeutics (ZVRA) Beats Q3 Earnings Estimates by $0.01

Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings beatARDXfinnhubNov 4, 2026

Ardelyx (ARDX) Beats Q3 Earnings Estimates by $0.02

Ardelyx (NASDAQ:ARDX) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings beatSGHCfinnhubNov 4, 2026

Super Group (SGHC) (SGHC) Beats Q3 Earnings Estimates by $0.11

Super Group (SGHC) (NYSE:SGHC) reported quarterly earnings results on November 03, 2026 that exceeded analyst expectations.

earnings missDNLIfinnhubNov 4, 2026

Denali Therapeutics (DNLI) Misses Q3 Earnings Expectations

Denali Therapeutics (NASDAQ:DNLI) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.

earnings missEROKfinnhubNov 4, 2026

EagleRock Land (EROK) Misses Q3 Earnings Expectations

EagleRock Land (NASDAQ:EROK) reported quarterly earnings results on November 03, 2026 that fell short of analyst expectations.

Featured By

Fate Therapeutics (FATE) Beats Q3 Earnings Estimates by $0.01

Filana Therapeutics (FLNA) Beats Q3 Earnings Estimates by $0.02

Korro Bio (KRRO) Beats Q3 Earnings Estimates by $0.26

Cabaletta Bio (CABA) Beats Q3 Earnings Estimates by $0.03

SCYNEXIS (SCYX) Misses Q3 Earnings Expectations

Dyne Therapeutics (DYN) Misses Q3 Earnings Expectations

Pyxis Oncology (PYXS) Beats Q3 Earnings Estimates by $0.04

RxSight (RXST) Beats Q3 Earnings Estimates by $0.02

Manitowoc Co (MTW) Beats Q3 Earnings Estimates by $0.11

Intrepid Potash (IPI) Misses Q3 Earnings Expectations

Ferroglobe (GSM) Misses Q3 Earnings Expectations

Primoris Services (PRIM) Beats Q3 Earnings Estimates by $0.43

JELD-WEN Holding (JELD) Beats Q3 Earnings Estimates by $0.01

LendingTree (TREE) Beats Q3 Earnings Estimates by $0.70

Safehold (SAFE) Misses Q3 Earnings Expectations

Zevra Therapeutics (ZVRA) Beats Q3 Earnings Estimates by $0.01

Ardelyx (ARDX) Beats Q3 Earnings Estimates by $0.02

Super Group (SGHC) (SGHC) Beats Q3 Earnings Estimates by $0.11

Denali Therapeutics (DNLI) Misses Q3 Earnings Expectations

EagleRock Land (EROK) Misses Q3 Earnings Expectations